According to the results of a global forecast mentioned in the report titled “Ultrasound Systems Market – Global Industry Analysis 2012 – 2021 and Opportunity Assessment 2022 – 2028,” the global Ultrasound Systems Market is anticipated to reach a market value of over US$ 13.2 Bn by the end of 2028, growing at an impressive …
Category Archives: Healthcare Trends
United Kingdom Nucleic Acid Testing Market is expected to surpass US$ 267.5 Million by 2033 at a CAGR of 6.7%
The global Nucleic Acid Testing Market is expected to reach US$ 3.7 billion by 2023. The market is expected to reach US$ 7.2 billion by 2033, growing at a strong 6.8% CAGR. Major factors influencing the growth of the nucleic acid amplification testing market include the rising incidence of infectious diseases, cancers, and other diseases, improvements in …
Rare Neurological Disease Treatment Market is expected to surpass US$ 19.795.14 Million by 2032 grow at an 8.7% CAGR
According to a recent analysis by Future Market Insights, the Rare Neurological Disease Treatment Market would experience phenomenal growth between 2022 and 2032. By the end of 2032, revenues from the treatment of uncommon neurological illnesses are expected to surpass US$ 19.795.14 million. According to a recent Future Market Insights report, the market for medications …
Genital Herpes Treatment Market | Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Dr. Reddy’s Laboratories ltd., Novartis AG | By 2031
The global Genital Herpes Treatment Market is predicted to grow rapidly and surpass US$ 2881.8 Mn by the end of 2031, per the report’s market forecasts. During the projected period of 2021–2031, the market is anticipated to see a CAGR of 4.5%. A typical sexually transmitted illness is genital herpes. The prevalence of health problems …
Breathing Circuits Market in Germany is set to expand at a CAGR of 4.0% from 2022 to 2032
By the end of 2022, the market for Breathing Circuits Market is anticipated to be worth US$ 1,163.32 Mn and grow at a CAGR of 4.2% from 2022 to 2032. By the end of 2032, the market is projected to be worth US$ 1,758.18 million. In 2021, open breathing circuits dominated the market with a 43.6% market …
DNA Methylation Market is predicted to be US$ 5815.49 Million at a CAGR of 15% by 2033 | FMI Analyst
During the forecast period 2023-2033, the DNA Methylation Market is expected to grow at a value of 15% CAGR, according to Future Market Insights. By the year 2033, the global market for DNA methylation is expected to rise up to a market valuation of US$ 5815.49 Million. Furthermore, the growing prevalence of esophageal adenocarcinoma has contributed to …
Aesthetic Medical Devices Market expected to reach a valuation of US$ 35 Billion at a CAGR of 9.6% by 2032 | FMI Report
A recently published study by FMI expects the global Aesthetic Medical Devices Market to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced …
Cardiovascular Ultrasound Market is expected to reach a US$ 2.6 billion valuation by 2032 | FMI Study
The Cardiovascular Ultrasound market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as …
Liver Fibrosis Treatment Market is expected to reach a valuation of US$ 46.65 Billion by 2033 | FMI
The global Liver Fibrosis Treatment Market is anticipated to exceed a remarkable valuation of US$ 16.43 billion in 2023, with a compound annual growth rate (CAGR) of 11% projected from 2023 to 2033. The rising prevalence of undesirable outcomes such as hepatitis B or C virus infection, an impaired immune system due to co-infection with …
Next Generation Immunotherapies Market is expected to reach a valuation of US$ 268.84 billion by 2033 | FMI Study
The global Next Generation Immunotherapies Market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, …